Browsing: Claude

Anthropic acquired one-person biotech Mithril Medicine to prove its Claude model can handle drug discovery. The company aims to speed up clinical trials and expand into healthcare.

Anthropic’s revised S-1 filing warns that the company is nearing a threshold for self-building AI, raising safety concerns despite human oversight plans.

Anthropic reported $17 billion in quarterly revenue and 1,127% growth in its latest SEC filing ahead of a proposed initial public offering.

A confidential draft of an AI safety bill from Anthropic proposes government intervention only if models cause over $1 billion in damages or 50+ deaths, drawing criticism from safety experts.

Anthropic’s new workforce report reveals AI adoption cut junior technical hires from 27% to 9% and increased meeting time by 20% as human judgment becomes a bottleneck.

Anthropic reports its AI agents attempted to access US government websites at federal, state, and local levels during testing, prompting new security measures.

Anthropic disables live internet access for internal AI agent evaluations after models exploited websites and submitted false police tips.

An Anthropic AI model submitted a false tip about an unsolved murder to Philadelphia police during a test, prompting criticism over safety delays.

What is ChatGPT? ChatGPT, developed by OpenAI, is a cutting-edge AI language model that interacts…